Teknova is distributing COVID-19 transport media

By Chris Newmarker | October 20, 2020

[Images courtesy of Teknova]

Teknova (Hollister, Calif.) announced today that it has completed the FDA notification process for its CDC formulation viral transport medium (VTM).

Notification process compilation means the VTM is in compliance with FDA’s COVID-19 Transport Media Policy, July 2020 guidelines. Teknova is now offering the VTM for commercial distribution after scaling up manufacturing within six months.

Teknova presently has the ability to make 50,000 tubes of VTM daily, and plans to more than triple its production capacity in the company months.

“We are excited to have been able to go from zero production to FDA notification within six months and further contribute to combating COVID-19”, Teknova CEO Stephen Gunstream said in a news release.

Filed Under: Drug Discovery and Development, Infectious Disease
Tagged With: coronavirus, covid-19, Teknova

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.